Reporter Cell Lines for Human Embryonic Development Toxicity Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current in vitro assays for developmental toxicity have limitations such as low predictive value, inability to detect human-specific teratogens, and high rates of false negatives, making them unreliable for assessing the teratogenic potential of compounds.
Innovation Solution
Development of a method using reporter cell lines with reporter sequences linked to specific regulatory elements of genes like OCT4, BMP4, MYH6, PAX6, FOXA2, SOX1, ALB, AFP, Ck18, and Vegfr1, which are transcriptionally activated or deactivated during embryonic development, allowing for the visualization and quantification of disturbances in signaling pathways and cell type-specific teratogenic effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of time
If in vitro assays are used to replace in vivo studies, then testing time is reduced and animal usage is decreased, but predictive value for human risk assessment remains low
Solution Approach 1:
The patent introduces reporter cell lines as an intermediary system between simple in vitro assays and complex in vivo studies. These reporter cells contain regulatory elements from human developmental genes (OCT4, PAX6, MYH6, etc.) that act as mediators to detect teratogenic effects with higher predictive value while maintaining the time and ethical advantages of in vitro testing.
Solution Approach 2:
The invention changes the parameters of in vitro assays by incorporating specific regulatory elements from human developmental genes into reporter cell lines. This transforms standard in vitro tests into more sophisticated assays that can detect disruptions in human embryonic development pathways, thereby improving predictive value without requiring in vivo conditions.
2Productivity
If standard in vitro assays are used, then testing is simpler and faster, but false negative rates are high and human-specific teratogens cannot be detected
Solution Approach 1:
The patent segments the complex process of embryonic development into specific gene regulatory pathways (OCT4 for pluripotency, PAX6 for neural development, MYH6 for cardiac development, etc.). Each reporter cell line targets a specific developmental pathway, allowing high-throughput screening while maintaining the ability to detect human-specific teratogens that affect particular developmental processes.
Solution Approach 2:
The reporter cell lines serve multiple functions: they can screen for general teratogenicity, detect human-specific teratogens, identify affected developmental pathways, and prioritize compounds for further testing. This multi-functionality maintains testing efficiency while dramatically improving detection accuracy across different teratogen types.
3Quantity of substance
If existing in vitro assays are used, then resource requirements are reduced, but the ability to assess developmental toxicity is insufficient
Solution Approach 1:
The patent creates simplified copies of human embryonic development pathways by inserting regulatory elements from developmental genes into reporter cell lines. These cellular copies reproduce key aspects of human embryonic gene regulation, enabling reliable toxicity assessment using minimal resources compared to in vivo studies, while maintaining human-specific detection capability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances the sensitivity and specificity of teratogenicity assessment, improving the classification of substances' hazard in early human embryonic development and accurately identifying teratogenic compounds.
Implementation Method 1
reporter sequences linked to specific regulatory elements of genes like OCT4, BMP4, MYH6, PAX6, FOXA2, SOX1, ALB, AFP, Ck18, and Vegfr1, which are transcriptionally activated or deactivated during embryonic development
Data Source
AI summary
The invention relates to the fields of developmental toxicity. In particular, it relates to novel reporter cell types that may be used in in vitro methods to determine the effect of an agent on mammalian embryonic development.